STAT3通路参与白细胞介素-22促进人结肠癌细胞系HT29紧密连接蛋白的表达

基础医学与临床 ›› 2021, Vol. 41 ›› Issue (6): 792-798.

STAT3通路参与白细胞介素-22促进人结肠癌细胞系HT29紧密连接蛋白的表达

宋茜¹, 黄雪^1*, 覃蒙斌², 张君红¹, 井洁¹, 罗毅华¹, 李雨芯¹

1.广西医科大学第一附属医院老年病学消化科, 广西壮族自治区南宁 530021;
2.广西医科大学第二附属医院消化内科,广西壮族自治区南宁 530000

收稿日期:2021-01-07 修回日期:2021-04-16 出版日期:2021-06-05 发布日期:2021-05-31
通讯作者: ^*hb960305@163.com
基金资助:
国家自然科学基金(81660093);广西研究生教育创新计划(YCSW2020112)

STAT3 pathway is involved in interleukin-22 promoting expression of tight junction protein in human colorectal cancer cell line HT29

SONG Qian¹, HUANG Xue^1*, QIN Meng-bin², ZHANG Jun-hong¹, JING Jie¹, LUO Yi-hua¹, LI Yu-xin¹

1. Department of Geriatric Gastroenterology, the First Affiliated Hospital, Guangxi Medical University, Nanning 530021;
2. Department of Gastroenterology, the Second Affiliated Hospital, Guangxi Medical University,Nanning 530000, China

Received:2021-01-07 Revised:2021-04-16 Online:2021-06-05 Published:2021-05-31
Contact: ^*hb960305@163.com

摘要/Abstract

摘要： 目的探讨白细胞介素-22(IL-22)对肠上皮屏障紧密连接的影响及机制。方法将人结肠癌细胞系HT29分为对照组、IL-22组(100 ng/mL)、FLLL32组(IL-22干预前使用FLLL32预处理)、colivelin组(IL-22干预前使用colivelin预处理)。转染处理组:shNC组、shNC+ IL-22组(IL-22干预前转染阴性对照)、shSTAT3组(转染LV-STAT3-RNAi)、shSTAT3+ IL-22组(IL-22干预前转染LV-STAT3-RNAi)。用Western blot、real-time PCR检测HT29细胞 STAT3、p-STAT3和紧密连接蛋白ZO-1、occludin、claudin-1和claudin-2及其mRNA的表达;用透射电镜观察HT29细胞紧密连接结构。结果相比于对照组,IL-22组的STAT3、p-STAT3、 ZO-1、occludin、claudin-1和claudin-2蛋白及mRNA表达水平明显升高(P＜0.05),且紧密连接更致密。相比于IL-22组,FLLL32组中上述指标的蛋白及mRNA表达量明显下调(P＜0.05),紧密连接较差,colivelin组则表达上调(P＜0.05),紧密连接完好。相比于shNC组,shNC+ IL-22组的所有紧密连接的蛋白及mRNA表达量明显增加(P＜0.05),紧密连接结构更致密;而相比于shSTAT3组,shSTAT3+ IL-22组的所有紧密连接的蛋白及mRNA表达量的差异无统计学意义。结论 STAT3通路参与IL-22促进HT29细胞紧密连接蛋白ZO-1、occludin、claudin-1和claudin-2的表达。

关键词: 紧密连接蛋白, 白细胞介素-22, STAT3, 溃疡性结肠炎, 肠上皮屏障

Abstract: Objective To investigate the effect of interleukin-22(IL-22) on intestinal epithelial barrier tight junction and its mechanism. Methods Human colon cancer HT29 cells were divided into control group, IL-22 group(100 ng/mL), FLLL32 group(pretreatment with FLLL32 before IL-22 intervention) and colivelin group(pretreatment with colivelin before IL-22 intervention). The transfection treatment groups included: shNC group, shNC+ IL-22 group(infection with negative control virus before IL-22 intervention), shSTAT3 group(infection with LV-STAT3-RNAi virus), and shSTAT3+ IL-22 group(LV-STAT3-RNAi virus infection before IL-22 intervention). Western blot and real-time PCR were used to detect the protein and mRNA expression of STAT3, p-STAT3 tight junction protein ZO-1, occludin, claudin-1 and claudin-2 in HT29 cells. Transmission electron microscopy(TEM) was used to observe the changes in the structure of tight junctions of HT29 cells. Results The protein and mRNA expression level of STAT3, p-STAT3, ZO-1, occludin, claudin-1 and claudin-2 in IL-22 group were significantly higher than those in the control group(P＜0.05) with more compact, tight junction. Compared with IL-22 group, protein and mRNA expression level of the above indexes in FLLL32 group were significantly decreased(P＜0.05), the tight junction was poor, the expression of colivelin group was up-regulated(P＜0.05), the tight junction was intact. The shNC+ IL-22 group significantly increased the expression of all tightly bound proteins and mRNA compared with the shNC group(P＜0.05), the tight junction structure was more dense, while the shSTAT3+ IL-22 group showed no significant difference in protein and mRNA expression level when compared with theose of shSTAT3 group. Conclusions STAT3 signaling pathway is involved in IL-22 to promote the expression of tight junction proteins ZO-1, occludin, claudin-1 and claudin-2 in HT29 cells.

Key words: tight junction protein, IL-22, STAT3, ulcerative colitis, intestinal epithelial barrier

中图分类号:

R319

宋茜, 黄雪, 覃蒙斌, 张君红, 井洁, 罗毅华, 李雨芯. STAT3通路参与白细胞介素-22促进人结肠癌细胞系HT29紧密连接蛋白的表达[J]. 基础医学与临床, 2021, 41(6): 792-798.

SONG Qian, HUANG Xue, QIN Meng-bin, ZHANG Jun-hong, JING Jie, LUO Yi-hua, LI Yu-xin. STAT3 pathway is involved in interleukin-22 promoting expression of tight junction protein in human colorectal cancer cell line HT29[J]. Basic & Clinical Medicine, 2021, 41(6): 792-798.

参考文献

[1] Ungaro R, Mehandru S, Allen PB, et al. Ulcerative colitis[J]. Lancet,2017,389:1756-1770.
[2] 甄建华,黄光瑞.溃疡性结肠炎病因和发病机制的现代医学研究进展[J]. 世界华人消化杂志,2019,27:245-251.
[3] 倪杰明,刘维新.肠黏膜屏障损伤在溃疡性结肠炎的作用研究进展[J]. 安徽医科大学学报,2018,53:815-818.
[4] Lameris AL, Huybers S, Kaukinen K, et al. Expression profiling of claudins in the human gastrointestinal tract in health and during inflammatory bowel disease[J]. Scand J Gastroenterol,2013,48:58-69.
[5] Lu Z, Ding L, Lu Q, et al. Claudins in intestines: Distribution and functional significance in health and diseases[J]. Tissue Barriers, 2013,1:e24978. doi: 10.4161/tisb.24978.
[6] 张冬妮,王忆安,李广文, 等. 帕金森病模型大鼠十二指肠黏膜紧密连接蛋白表达下调[J]. 基础医学与临床,2017,37:1359-1362.
[7] Emami CN, Chokshi N, Wang J, et al. Role of interleukin-10 in the pathogenesis of necrotizing entero-colitis[J]. Am J Surg,2012,203:428-435.
[8] Mizoguchi A, Yano A, Himuro H, et al. Clinical importance of IL-22 cascade in IBD[J]. J Gastroenterol, 2018,53:465-474.
[9] Rutz S, Wang X, Ouyang W. The IL-20 subfamily of cytokines-from host defence to tissue homeostasis[J]. Nat Rev Immunol, 2014,14:783-795.
[10] Sabat R, Ouyang W, Wolk K. Therapeutic opportunities of the IL-22-IL-22R1 system[J]. Nat Rev Drug Discov,2014,13:21-38.
[11] 李茹柳, 迟莉, 郭文峰, 等. 紧密连接蛋白occludin和claudin-1在大鼠溃疡性结肠炎的表达[J]. 广州中医药大学学报, 2008, 25:83-87,90.
[12] Ashizuka S, Inagaki-Ohara K, Kuwasako K, et al. Adrenomedullin treatment reduces intestinal inflammation and maintains epithelial barrier function in mice administered dextran sulphate sodium[J]. Microbiol Immunol,2009,53: 573-581.
[13] Ouyang W. Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease[J]. Cytokine Growth Factor Rev,2010, 21:435-441.
[14] 成海燕,张亚姝,迟宏罡.IL-22及肠道干细胞在肠黏膜屏障中的作用[J]. 广东医学,2016,37:3133-3135.

[1]	尤丽丽, 杨丽潇, 王思瑶, 钱娜, 卢敏, 宋萌, 关玉霞. 炎性肠病患者衰弱风险预测模型的构建及评价[J]. 基础医学与临床, 2023, 43(7): 1127-1133.
[2]	邓博雅, 路亚岚, 羽思, 张旖垚, 黄婧怡, 李玥, 刘长征. E3泛素连接酶RNF138抑制溃疡性结肠炎的发生及进展[J]. 基础医学与临床, 2023, 43(6): 941-947.
[3]	秦玉春, 邝向东, 蔡林再, 谢景臣, 陈山. 双氢青蒿素减轻慢性阻塞性肺疾病(COPD)模型大鼠肺损伤[J]. 基础医学与临床, 2023, 43(3): 427-432.
[4]	刘怡斐, 王鑫宇, 王嘉慧, 杜晓冰, 王途, 赵娟. 尾加压素Ⅱ受体拮抗剂(urantide)减轻动脉粥样硬化大鼠肾脏损伤[J]. 基础医学与临床, 2023, 43(11): 1668-1672.
[5]	孙晓丽, 张进进, 宋凤英, 黄永莉, 陈立力, 邢颜超. Tim-3/galectin-9调控脂多糖诱导的人淋巴细胞中Th1/Th2细胞平衡[J]. 基础医学与临床, 2023, 43(10): 1542-1548.
[6]	孙欣昭, 罗艳露, 范江涛, 钟雪艳. STAT3在子宫内膜癌中的表达及其临床病理意义[J]. 基础医学与临床, 2023, 43(10): 1577-1579.
[7]	牛世伟, 苏韫, 龚红霞, 李婷婷, 曾元丁, 张晗, 聂蓬. 胃癌患者血清IL-1的升高和癌组织JAK2/STAT3信号通路的激活[J]. 基础医学与临床, 2022, 42(3): 401-405.
[8]	陈茜, 刘宪, 崔南, 翟阳. 敲除EZH2抑制人宫颈癌细胞系迁移和侵袭[J]. 基础医学与临床, 2022, 42(3): 395-400.
[9]	师丽, 袁浩, 刘敏, 郑亚, 王玉平, 郭庆红. 胆红素在炎性肠病中作用的研究进展[J]. 基础医学与临床, 2022, 42(12): 1925-1929.
[10]	吴长宝, 郝延磊. STAT3与帕金森病发病机制的研究进展[J]. 基础医学与临床, 2022, 42(12): 1935-1938.
[11]	陈号, 陈韬, 吴静. IL-6/JAK/STAT3信号通路在前列腺癌发展和治疗中的研究进展[J]. 基础医学与临床, 2022, 42(1): 159-162.
[12]	李雨芯, 余雪嫣, 黄雪. 白芨多糖上调溃疡性结肠炎小鼠肠黏膜紧密连接蛋白occludin的表达[J]. 基础医学与临床, 2021, 41(7): 941-945.
[13]	李春美, 赵微, 解相宏, 张伟虹, 杨佳卉, 李军, 刘晓军. 青稞酥油饮食对小鼠肠道菌群以及葡聚糖硫酸钠诱导的小鼠结肠炎症状的影响[J]. 基础医学与临床, 2021, 41(2): 203-208.
[14]	黎笑兰, 张新广, 尹少萍. 白芨多糖抑制溃疡性结肠炎大鼠炎性反应与氧化应激[J]. 基础医学与临床, 2020, 40(2): 224-228.
[15]	段亚菊, 王文茜, 胡华, 付丹丹, 宋向凤, 田中伟. IL-33对人永生化角质形成细胞系和模型小鼠银屑病样皮损的影响[J]. 基础医学与临床, 2020, 40(1): 67-72.